NBTX (Nanobiotix S.A. American Depositary Shares) Stock Analysis - Analyst Ratings

Nanobiotix S.A. American Depositary Shares (NBTX) is a publicly traded Healthcare sector company. As of May 21, 2026, NBTX trades at $41.84 with a market cap of $2.40B and a P/E ratio of 0.00. NBTX moved -7.86% today. Year to date, NBTX is +106.61%; over the trailing twelve months it is +1018.13%. Its 52-week range spans $2.76 to $57.14. Analyst consensus is strong buy with an average price target of $34.33. Rallies surfaces NBTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate NBTX?

4 analysts cover NBTX: 0 strong buy, 3 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $34.33.

NBTX Key Metrics

Key financial metrics for NBTX
MetricValue
Price$41.84
Market Cap$2.40B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$57.14
52-Week Low$2.76
Volume898
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

NBTX Analyst Consensus

4 analysts cover NBTX: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.33.

Latest NBTX News

Common questions about NBTX

What do analysts rate NBTX?
4 analysts cover NBTX: 0 strong buy, 3 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $34.33.
Does Rallies show NBTX price targets?
Yes. Rallies tracks NBTX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is NBTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NBTX. It does not provide personalized investment advice.
NBTX

NBTX